| Naziv |
Akcije |
| Bašić-Kinda, Sandra
Izraženost i klinički značaj galektina-3, VEGF-a i NF-κB u difuznom B-velikostaničnom limfomu / Aurer, Igor (mentor);
Zagreb, Medicinski fakultet u Zagrebu, 2023 |
|
| (EORTC Lymphoma Group) Fornecker, Luc-Matthieu ; Lazarovici, Julien ; Aurer, Igor ; Casasnovas, René-Olivier ; Gac, Anne-Claire ; Bonnet, Christophe ; Bouabdallah, Krimo ; Feugier, Pierre ; Specht, Lena ; Molina, Lysiane et al.
Brentuximab Vedotin Plus AVD for First-Line Treatment of Early-Stage Unfavorable Hodgkin Lymphoma (BREACH): A Multicenter, Open-Label, Randomized, Phase II Trial // Journal of clinical oncology, 41 (2023), 2; 327-335. doi: 10.1200/jco.21.01281 |
|
| Premužić, Vedran ; Bašić-Kinda, Sandra ; Radman, Ivo ; Dujmović, Dino ; Ilić, Ivana ; Živković, Neno ; Maleta, Lucija ; Kralik, Marko ; Dobrenić, Margareta ; Galunić-Bilić, Lea et al.
Glomerular filtration rate is an independent prognostic factor in patients with B-large cell lymphoma // Medicine, 102 (2023), 20; 33675, 5. doi: 10.1097/MD.0000000000033675 |
|
| (KroHem) Mitrović, Zdravko ; Dujmović, Dino ; Jakšić, Ozren ; Bašić-Kinda, Sandra ; Gaćina, Petar ; Periša, Vlatka ; Prka, Željko ; Dreta, Barbara ; Galušić Davor ; Holik, Hrvoje et al.
Dose-adjusted EPOCH and rituximab (DA-EPOCH-R) in older patients with high-risk aggressive diffuse large B-cell lymphoma: A real-life multicenter study by the Croatian Cooperative Group for Hematologic diseases (KroHem) // European journal of haematology, 111 (2023), 13957, 7. doi: 10.1111/ejh.13957 |
|
| Galunić Bilić, Lea ; Šantek, Fedor ; Grah, Josip Joachim ; Bašić-Kinda, Sandra ; Mandac Smoljanović, Inga ; Ostojić Kolonić, Slobodanka ; Mitrović, Zdravko ; Vodanović, Marijo ; Dujmović, Dino ; Aurer, Igor
Efficacy and toxicity of infradiaphragmal radiotherapy fields in lymphoma patients: a single-centre experience // Radiologia medica, 128 (2023), 1615, 9. doi: 10.1007/s11547-023-01615-8 |
|
| Lalić, Hrvoje ; Aurer, Igor ; Batinić, Drago ; Višnjić, Dora ; Smoljo, Tomislav ; Babić, Antonija
Bendamustine: a review of pharmacology, clinical use and immunological effects (Review) // Oncology reports, 47 (2022), 6; 114, 16. doi: 10.3892/or.2022.8325 |
|
| Dreyling, Martin ; André, Marc ; Gökbuget, Nicola ; Tilly, Hervé ; Jerkeman, Mats ; Gribben, John ; Ferreri, Andrés ; Morel, Pierre ; Stilgenbauer, Stephan ; Fox, Christopher et al.
The EHA Research Roadmap: Malignant Lymphoid Diseases // HemaSphere, 6 (2022), 6; e726, 18. doi: 10.1097/hs9.0000000000000726 |
|
| Galušić, Davor ; Bašić-Kinda, Sandra ; Pijuk, Anđela ; Milunović, Vibor ; Dreta, Barbara ; Franjić, Neven ; Coha, Božena ; Sinčić-Petričević, Jasminka ; Gaćina, Petar ; Pejša, Vlatko et al.
Efficacy and Safety of Obinutuzumab-chemotherapy Combinations in Front-line Treatment of Follicular Non-Hodgkin Lymphoma During the COVID-19 Pandemic: A Study of KROHEM, the Croatian Cooperative Group for Hematologic Diseases // HemaSphere, 6 (2022), 12; e807, 6. doi: 10.1097/HS9.0000000000000807 |
|
| Batinić, Josip ; Vodanović, Marijo ; Rončević, Pavle ; Aurer, Igor
Hematologija // Primjeri u kliničkoj medicini / Premužić, Vedran (ur.). Zagreb: Alfa, 2022. str. 55-73 |
|
| Milunović, Vibor ; Hude, Ida ; Rinčić, Goran ; Galušić, Davor ; Grubešić, Aron ; Martinović, Marko ; Popović, Nika ; Divošević, Sunčana ; Brčić, Klara ; Međugorac, Marin et al.
Clinical Dilemmas in the Treatment of Elderly Patients Suffering from Hodgkin Lymphoma: A Review // Biomedicines, 10 (2022), 11; 2917, 22. doi: 10.3390/biomedicines10112917 |
|
